Spectrum Pharmaceuticals Inc

SPPI

NASDAQ. Currency in USD

0.46 +0.03 ( +7.63% )

Real time prices: September 26

Market Cap.
86.56M
Beta (5Y monthly)
1.85
Price/Earnings
-
EPS (TTM)
-0.73
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Dec 20, 2012
Volume
7.51M
1y Target Est.
6.00
Day's Range
0.42
-
0.47
52 Week's Range
0.41
-
2.45

Historical Summary

Performance
EPS growth
Share Buybacks

About Spectrum Pharmaceuticals Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.sppirx.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
163.96M
Employees
163
Address
Pilot House ? Lewis Wharf, Boston, MA, United States, 02110
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Boston, Massachusetts.

Latest news

Spectrum (SPPI) Down as FDA Panel Votes Against NSCLC Drug
Spectrum (SPPI) Down as FDA Panel Votes Against NSCLC Drug

The FDA Oncologic Drugs Advisory Committee votes against Spectrum's (SPPI) poziotinib for treating non-small cell...
By Zacks Investment Research - 11 hours ago

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89...
By Benzinga - 20 hours ago

Dow Hits New 2022 Low; Gold Falls Sharply
Dow Hits New 2022 Low; Gold Falls Sharply

U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping to...
By Benzinga - 3 days ago

Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says Analyst
Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says Analyst

Yesterday, the FDA's Oncologic Drugs Advisory Committee (ODAC) panel voted against Spectrum Pharmaceuticals Inc's (NASDAQ:...
By Benzinga - 3 days ago

Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on...
By Benzinga - 3 days ago

Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply
Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200...
By Benzinga - 3 days ago

Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket

Gainers HHG Capital Corporation (NASDAQ: HHGC) shares rose 42.1% to $14.56 in pre-market trading. Rubius...
By Benzinga - 3 days ago

With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma

On Tuesday, the FDA released briefing documents related to Spectrum Pharmaceutical Inc's (NASDAQ: SPPI) application...
By Benzinga - 5 days ago